HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- With many cannabis products but limited research, ‘education warranted’ for entire oncology workforce Jennifer Byrne
-
- Should insurance companies cover medical marijuana for cancer pain?
- Family: The most important thing in life Nicholas J. Petrelli, MD, FACS
- Antiracism intervention reduces disparities in timely lung cancer surgery Jennifer R. Southall
- Cancer survivors undergoing treatment more likely to believe COVID-19 misinformation Ryan Lawrence
- Gene therapy increases factor VIII activity, reduces bleeding in severe hemophilia A Ryan Lawrence
- MAPK mutations linked to longer survival in ovarian cancer subset Jennifer R. Southall
- Music therapy helps patients with sickle cell disease cope with pain Jennifer Byrne; Sam Rodgers-Melnick, MT-BC
- Patients with non-small lung cancer with CTLA-4 variant may respond better to immunotherapy Ryan Lawrence
-
- Point-of-care CAR-T shows ‘promising’ efficacy, safety for B-cell non-Hodgkin lymphoma Drew Amorosi
- Race linked to increased treatment interruptions among women with gynecologic cancer Jennifer R. Southall
- Sotorasib active, safe for certain patients with advanced pancreatic cancer Ryan Lawrence
- Three-drug regimen may reduce relapse risk after transplant for T-cell malignancies Ryan Lawrence
- Toripalimab plus initial chemotherapy prolongs PFS, OS in non-small cell lung cancer Jennifer R. Southall
- Cedars-Sinai Cancer names medical director of clinical trials office
- NCI scientist to receive award for achievement in cancer research